Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV 26505, USA.
J Pharmacol Exp Ther. 2011 Aug;338(2):711-7. doi: 10.1124/jpet.111.180828. Epub 2011 May 23.
The NADPH oxidase (Nox) subunits 1, 2 (gp91 phox), and 4 are the major sources for reactive oxygen species (ROS) in vascular tissues. In conditions such as ischemia-reperfusion and hypoxia, both ROS and adenosine are released, suggesting a possible interaction. Our aim in this study was to examine the A(3) adenosine receptor (A(3)AR)-induced vascular effects and its relation to ROS and Nox1, 2, and 4 using aortic tissues from wild-type (WT) and A(3)AR knockout (A(3)KO) mice. The selective A(3)AR agonist 2-chloro-N(6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (Cl-IBMECA) (10(-10)-10(-5) M) induced contraction of the aorta from WT but not from A(3)KO mice, and this contraction was inhibited by the Nox inhibitor apocynin (10(-5) M) and the ROS scavengers superoxide dismutase-polyethylene glycol and catalase-polyethylene glycol (100 U/ml each). Cl-IBMECA-induced contraction was not affected by the mast cell degranulator compound 48/80 (100 μg/ml) or the stabilizer cromolyn sodium (10(-4) M). In addition, Cl-IBMECA (10(-7) M) increased intracellular ROS generation by 35 ± 14% in WT but not in A(3)KO aorta, and this increase was inhibited by apocynin (10(-5) M), diphenyleneiodonium chloride (10(-5) M), and the A(3)AR antagonist 3-propyl-6-ethyl-5-[(ethylthio)carbonyl]-2 phenyl-4-propyl-3-pyridine carboxylate (MRS1523) (10(-5) M). Furthermore, Cl-IBMECA selectively increased the protein expression of the Nox2 subunit by 150 ± 15% in WT but not in A(3)KO mice without affecting either Nox1 or 4, and this increase was inhibited by apocynin. The mRNA of Nox2 was unchanged by Cl-IBMECA in either WT or A(3)KO aortas. In conclusion, A(3)AR enhances ROS generation, possibly through activation of Nox2, with subsequent contraction of the mouse aorta.
NADPH 氧化酶(Nox)亚基 1、2(gp91 phox)和 4 是血管组织中活性氧(ROS)的主要来源。在缺血再灌注和缺氧等情况下,ROS 和腺苷同时释放,提示可能存在相互作用。我们的研究目的是使用野生型(WT)和 A3 受体敲除(A3KO)小鼠的主动脉组织,研究 A3 腺苷受体(A3AR)诱导的血管效应及其与 ROS 和 Nox1、2 和 4 的关系。选择性 A3AR 激动剂 2-氯-N6-(3-碘苄基)-腺苷-5'-N-甲基尿苷酰胺(Cl-IBMECA)(10-10-10-5 M)诱导 WT 小鼠但不诱导 A3KO 小鼠的主动脉收缩,该收缩被 Nox 抑制剂 apocynin(10-5 M)和 ROS 清除剂超氧化物歧化酶聚乙二醇和过氧化氢酶聚乙二醇(各 100 U/ml)抑制。Cl-IBMECA 诱导的收缩不受肥大细胞脱颗粒剂化合物 48/80(100 μg/ml)或稳定剂 cromolyn 钠(10-4 M)的影响。此外,Cl-IBMECA(10-7 M)在 WT 但不在 A3KO 主动脉中增加 35±14%的细胞内 ROS 生成,该增加被 apocynin(10-5 M)、二苯基碘氯化物(10-5 M)和 A3AR 拮抗剂 3-丙基-6-乙基-5-(乙基硫代)羰基-2-苯基-4-丙基-3-吡啶羧酸酯(MRS1523)(10-5 M)抑制。此外,Cl-IBMECA 选择性地增加 WT 但不增加 A3KO 小鼠中 Nox2 亚基的蛋白表达 150±15%,而不影响 Nox1 或 4,并且该增加被 apocynin 抑制。Cl-IBMECA 对 WT 或 A3KO 主动脉的 Nox2 mRNA 无影响。总之,A3AR 通过激活 Nox2 增强 ROS 生成,随后导致小鼠主动脉收缩。